Biotech Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for the Treatment of Still’s Disease December 22, 2020
Biotech Acer Therapeutics Announces Full Enrollment of Pivotal Bioequivalence Trial of ACER-001 for Urea Cycle Disorders December 22, 2020
Biotech Cocrystal Pharma Selects Lead Compound for Further Development Against Coronaviruses December 22, 2020
Biotech Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures December 22, 2020
Biotech Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During “J.P. Morgan Week 2021” December 22, 2020
Biotech Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 for COVID-19 December 22, 2020
Biotech Evofem Biosciences to Participate in Medicaid National Drug Rebate Program for Phexxi® Effective January 1, 2021 December 22, 2020
Biotech Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020 December 22, 2020